Literature DB >> 30125127

Moving from the Trial to the Real World: Improving Medication Adherence Using Insights of Implementation Science.

Leah L Zullig1,2, Mieke Deschodt3,4, Jan Liska5, Hayden B Bosworth1,2, Sabina De Geest3,6.   

Abstract

Medication nonadherence is a serious public health concern. Although there are promising interventions that improve medication adherence, most interventions are developed and tested in tightly controlled research environments that are dissimilar from the real-world settings where the majority of patients receive health care. Implementation science methods have the potential to facilitate and accelerate the translation shift from the trial world to the real world. We demonstrate their potential by reviewing published, high-quality medication adherence studies that could potentially be translated into clinical practice yet lack essential implementation science building blocks. We further illustrate this point by describing an adherence study that demonstrates how implementation science creates a junction between research and real-world settings. This article is a call to action for researchers, clinicians, policy makers, pharmaceutical companies, and others involved in the delivery of care to adopt the implementation science paradigm in the scale-up of adherence (research) programs.

Entities:  

Keywords:  behavioral interventions; chronic disease; dissemination; evidence-based; implementation science; medication adherence

Mesh:

Year:  2018        PMID: 30125127     DOI: 10.1146/annurev-pharmtox-010818-021348

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  7 in total

1.  Reimbursed Medication Adherence Enhancing Interventions in European Countries: Results of the EUREcA Study.

Authors:  Tamás Ágh; Maja Ortner Hadžiabdić; Kristina Garuoliene; Anne Gerd Granas; Emma Aarnio; Enrica Menditto; João Gregório; Pilar Barnestein-Fonseca; Vildan Mevsim; Przemysław Kardas
Journal:  Front Pharmacol       Date:  2022-06-17       Impact factor: 5.988

2.  Developing a medication adherence technologies repository: proposed structure and protocol for an online real-time Delphi study.

Authors:  Urska Nabergoj Makovec; Catherine Goetzinger; Janette Ribaut; Pilar Barnestein-Fonseca; Frederik Haupenthal; Maria Teresa Herdeiro; Sean Patrick Grant; Cristina Jácome; Fatima Roque; Dins Smits; Ivana Tadic; Alexandra L Dima
Journal:  BMJ Open       Date:  2022-04-22       Impact factor: 3.006

3.  Impact of Social Determinants of Health and Demographics on Refill Requests by Medicare Patients Using a Conversational Artificial Intelligence Text Messaging Solution: Cross-Sectional Study.

Authors:  Rena Brar Prayaga; Ridhika Agrawal; Benjamin Nguyen; Erwin W Jeong; Harmony K Noble; Andrew Paster; Ram S Prayaga
Journal:  JMIR Mhealth Uhealth       Date:  2019-11-18       Impact factor: 4.773

4.  Changes in Beliefs About Post-Transplant Immunosuppressants Over Time and Its Relation to Medication Adherence and Kidney Graft Dysfunction: A Follow-Up Study.

Authors:  Barbora Kostalova; Katerina Mala-Ladova; Ales Antonin Kubena; Rob Horne; Sylvie Dusilova Sulkova; Josef Maly
Journal:  Patient Prefer Adherence       Date:  2021-12-31       Impact factor: 2.711

5.  A data-driven typology of asthma medication adherence using cluster analysis.

Authors:  Holly Tibble; Amy Chan; Edwin A Mitchell; Elsie Horne; Dimitrios Doudesis; Rob Horne; Mehrdad A Mizani; Aziz Sheikh; Athanasios Tsanas
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

6.  Theory-driven development of a medication adherence intervention delivered by eHealth and transplant team in allogeneic stem cell transplantation: the SMILe implementation science project.

Authors:  Janette Ribaut; Lynn Leppla; Alexandra Teynor; Sabine Valenta; Fabienne Dobbels; Leah L Zullig; Sabina De Geest
Journal:  BMC Health Serv Res       Date:  2020-09-02       Impact factor: 2.655

7.  The rates and measurement of adherence to acamprosate in randomised controlled clinical trials: A systematic review.

Authors:  Kim Donoghue; Laura Hermann; Eileen Brobbin; Colin Drummond
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.